Anja L. Williams

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Phase 1/2 study of IMC-C103C, a T cell receptor bispecific (MAGE-A4×CD3) ImmTAC targeting MAGE-A4-expressing malignancies.

Phase 1/2 study of IMC-C103C, a T cell receptor bispecific (MAGE-A4×CD3) ImmTAC targeting MAGE-A4-expressing malignancies.

Journal: Journal for immunotherapy of cancer
Published: July 07, 2026

Survivin recombinant overlapping peptide (ROP) vaccine in advanced solid tumours: a first-in-human, multicentre, open-label, phase 1a dose-escalation study.

Survivin recombinant overlapping peptide (ROP) vaccine in advanced solid tumours: a first-in-human, multicentre, open-label, phase 1a dose-escalation study.

Journal: EClinicalMedicine
Published: September 11, 2025

Safety and Activity of Fibroblast Growth Factor Receptor Inhibitors in Advanced Malignancies: A Pooled Analysis of Early-Phase Clinical Trials.

Safety and Activity of Fibroblast Growth Factor Receptor Inhibitors in Advanced Malignancies: A Pooled Analysis of Early-Phase Clinical Trials.

Journal: JCO precision oncology
Published: April 16, 2025

A Phase I Dose Escalation and Cohort Expansion Study of CB307, a Trispecific Humabody against PSMA, CD137, and Albumin in Patients with PSMA-Positive Solid Tumors.

A Phase I Dose Escalation and Cohort Expansion Study of CB307, a Trispecific Humabody against PSMA, CD137, and Albumin in Patients with PSMA-Positive Solid Tumors.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 29, 2024

Outcomes of patients with refractory upper GI cancers enrolled in phase I trials: a 10-year analysis from the Sarah Cannon Research Institute UK Drug Development Unit.

Outcomes of patients with refractory upper GI cancers enrolled in phase I trials: a 10-year analysis from the Sarah Cannon Research Institute UK Drug Development Unit.

Journal: Therapeutic advances in medical oncology
Published: August 05, 2024

EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis.

EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis.

Journal: Allergy
Published: September 20, 2017

Reproducibility of task activation using the Addenbrooke's cognitive examination in healthy controls: A functional Transcranial Doppler ultrasonography study.

Reproducibility of task activation using the Addenbrooke's cognitive examination in healthy controls: A functional Transcranial Doppler ultrasonography study.

Journal: Journal of neuroscience methods
Published: May 24, 2017

Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis.

Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis.

Journal: Allergy
Published: May 04, 2017

Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study.

Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study.

Journal: Gut
Published: March 21, 2017

Transcranial Doppler ultrasonography in the assessment of neurovascular coupling responses to cognitive examination in healthy controls: A feasibility study.

Transcranial Doppler ultrasonography in the assessment of neurovascular coupling responses to cognitive examination in healthy controls: A feasibility study.

Journal: Journal of neuroscience methods
Published: January 02, 2017

Determining 'age at death' for forensic purposes using human bone by a laboratory-based biomechanical analytical method.

Determining 'age at death' for forensic purposes using human bone by a laboratory-based biomechanical analytical method.

Journal: Journal of the mechanical behavior of biomedical materials
Published: June 12, 2013
Showing 1-11 of 11

Last Updated: 09/26/2026